Bumper Offer - Urjas oil Just @ Rs. 1
Emikacin is a prescription medicine that is available as a Injection. Urinary Tract Infection are some of its major therapeutic uses. Other than this, Emikacin has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Emikacin is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Emikacin have been listed ahead. Normally, these side effects of Emikacin are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Emikacin has a Severe effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Emikacin's effects on the liver, heart and kidney, if any, have been listed below.
Emikacin is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. Other conditions have been mentioned below in the Emikacin contraindications section.
Drug interactions for Emikacin have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Emikacin, it is important to know that it is safe while driving, and is habit-forming.
Emikacin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Emikacin is used -
Moderate
Mild
Unknown
Is the use of Emikacin safe for pregnant women?
Pregnant women may get severe side effects after taking Emikacin. If you are pregnant, do not take Emikacin without a doctor's advice.
Is the use of Emikacin safe during breastfeeding?
In the absence of any scientific study about the side effects of Emikacin in breastfeeding women, information on safety of Emikacin is unavailable.
What is the effect of Emikacin on the Kidneys?
Consumption of Emikacin can harm the kidneys. So it is important to take medical advice beforehand.
What is the effect of Emikacin on the Liver?
Emikacin may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Emikacin on the Heart?
Emikacin is rarely harmful for the heart.
Emikacin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Emikacin unless your doctor advises you to do so -
Is this Emikacin habit forming or addictive?
No, there is no any evidence that Emikacin is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Emikacin will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Emikacin only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Emikacin in mental disorders is not effective.
Interaction between Food and Emikacin
You can take Emikacin with food.
Interaction between Alcohol and Emikacin
It is difficult to say anything about the effect of Emikacin and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
